These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7583547)

  • 41. Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation.
    Wilson DE; Emi M; Iverius PH; Hata A; Wu LL; Hillas E; Williams RR; Lalouel JM
    J Clin Invest; 1990 Sep; 86(3):735-50. PubMed ID: 2394828
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phenotypic variability in 4 homozygous familial hypercholesterolemia siblings compound heterozygous for LDLR mutations.
    Rabacchi C; Bigazzi F; Puntoni M; Sbrana F; Sampietro T; Tarugi P; Bertolini S; Calandra S
    J Clin Lipidol; 2016; 10(4):944-952.e1. PubMed ID: 27578127
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolic studies in familial hypercholesterolemia. Evidence for a gene-dosage effect in vivo.
    Bilheimer DW; Stone NJ; Grundy SM
    J Clin Invest; 1979 Aug; 64(2):524-33. PubMed ID: 222811
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group.
    Groenemeijer BE; Hallman MD; Reymer PW; Gagné E; Kuivenhoven JA; Bruin T; Jansen H; Lie KI; Bruschke AV; Boerwinkle E; Hayden MR; Kastelein JJ
    Circulation; 1997 Jun; 95(12):2628-35. PubMed ID: 9193431
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Macrophage lipoprotein lipase expression is increased in patients with heterozygous familial hypercholesterolemia.
    Beauchamp MC; Letendre E; Renier G
    J Lipid Res; 2002 Feb; 43(2):215-22. PubMed ID: 11861663
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship between apolipoprotein(a) phenotype, lipoprotein(a) concentration in plasma, and low density lipoprotein receptor function in a large kindred with familial hypercholesterolemia due to the pro664----leu mutation in the LDL receptor gene.
    Soutar AK; McCarthy SN; Seed M; Knight BL
    J Clin Invest; 1991 Aug; 88(2):483-92. PubMed ID: 1830890
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FH-Freiburg: a novel missense mutation (C317Y) in growth factor repeat A of the low density lipoprotein receptor gene in a German patient with homozygous familial hypercholesterolemia.
    Nauck MS; Scharnagl H; Nissen H; Schürmann C; Matern D; Nauck MA; Wieland H; März W
    Atherosclerosis; 2000 Aug; 151(2):525-34. PubMed ID: 10924730
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A double mutant [N543H+2393del9] allele in the LDL receptor gene in familial hypercholesterolemia: effect on plasma cholesterol levels and cardiovascular disease.
    Castillo S; Reyes G; Tejedor D; Mozas P; Suarez Y; Lasuncion MA; Cenarro A; Civeira F; Alonso R; Mata P; Pocovi M;
    Hum Mutat; 2002 Dec; 20(6):477. PubMed ID: 12442279
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of obesity on HDL and LDL particle sizes in carriers of the null P207L or defective D9N mutation in the lipoprotein lipase gene: the Québec LipD Study.
    Ruel IL; Gaudet D; Perron P; Bergeron J; Julien P; Lamarche B;
    Int J Obes Relat Metab Disord; 2003 May; 27(5):631-7. PubMed ID: 12704407
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diversity in expression of heterozygous familial hypercholesterolemia. Characterization of a unique kindred.
    Levy RA; Ostlund RE; Semenkovich CF; Witztum JL
    J Clin Invest; 1986 Jul; 78(1):96-101. PubMed ID: 3722389
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Common mutations in the low-density-lipoprotein-receptor gene causing familial hypercholesterolemia in the Japanese population.
    Maruyama T; Miyake Y; Tajima S; Harada-Shiba M; Yamamura T; Tsushima M; Kishino B; Horiguchi Y; Funahashi T; Matsuzawa Y
    Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1713-8. PubMed ID: 7583548
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fh-Souassi: a founder frameshift mutation in exon 10 of the LDL-receptor gene, associated with a mild phenotype in Tunisian families.
    Slimane MN; Lestavel S; Sun X; Maatouk F; Soutar AK; Ben Farhat MH; Clavey V; Benlian P; Hammami M
    Atherosclerosis; 2001 Feb; 154(3):557-65. PubMed ID: 11257256
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasma triglycerides related decrease in high-density lipoprotein cholesterol and its association with myocardial infarction in heterozygous familial hypercholesterolemia.
    Moorjani S; Gagné C; Lupien PJ; Brun D
    Metabolism; 1986 Apr; 35(4):311-6. PubMed ID: 3959903
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of lovastatin and probucol in treatment of familial and non-familial hypercholesterolemia: different effects on lipoprotein profiles.
    Helve E; Tikkanen MJ
    Atherosclerosis; 1988 Aug; 72(2-3):189-97. PubMed ID: 3063268
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia.
    Chan DC; Pang J; Hooper AJ; Burnett JR; Bell DA; Bates TR; van Bockxmeer FM; Watts GF
    Int J Cardiol; 2015 Dec; 201():633-8. PubMed ID: 26340131
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Different VLDL apo B, and HDL apo AI and apo AII metabolism in two heterozygous carriers of unrelated mutations in the lipoprotein lipase gene.
    Pérez-Méndez O; Duhal N; Lacroix B; Bonte JP; Fruchart JC; Luc G
    Clin Chim Acta; 2006 Jun; 368(1-2):149-54. PubMed ID: 16487502
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Familial hypercholesterolemia/autosomal dominant hypercholesterolemia: Molecular defects, the LDL-C continuum, and gradients of phenotypic severity.
    Foody JM; Vishwanath R
    J Clin Lipidol; 2016; 10(4):970-986. PubMed ID: 27578130
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhanced cholesteryl ester transfer protein activities and abnormalities of high density lipoproteins in familial hypercholesterolemia.
    Inazu A; Koizumi J; Mabuchi H; Kajinami K; Takeda R
    Horm Metab Res; 1992 Jun; 24(6):284-8. PubMed ID: 1634194
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Small, dense high-density lipoprotein 3 particles exhibit defective antioxidative and anti-inflammatory function in familial hypercholesterolemia: Partial correction by low-density lipoprotein apheresis.
    Hussein H; Saheb S; Couturier M; Atassi M; Orsoni A; Carrié A; Therond P; Chantepie S; Robillard P; Bruckert E; Chapman MJ; Kontush A
    J Clin Lipidol; 2016; 10(1):124-33. PubMed ID: 26892129
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Contribution of receptor negative versus receptor defective mutations in the LDL-receptor gene to angiographically assessed coronary artery disease among young (25-49 years) versus middle-aged (50-64 years) men.
    Gaudet D; Vohl MC; Couture P; Moorjani S; Tremblay G; Perron P; Gagné C; Després JP
    Atherosclerosis; 1999 Mar; 143(1):153-61. PubMed ID: 10208490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.